In the COAPT trial, transcatheter mitral valve repair with the MitraClip plus guideline directed medical therapy (GDMT) improved 2-year clinical outcomes in comparison to GDMT alone in symptomatic patients with… Click to show full abstract
In the COAPT trial, transcatheter mitral valve repair with the MitraClip plus guideline directed medical therapy (GDMT) improved 2-year clinical outcomes in comparison to GDMT alone in symptomatic patients with heart failure (HF) and 3+ or 4+ secondary mitral regurgitation (SMR) due to LV
               
Click one of the above tabs to view related content.